Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical timolol for early-stage superficial infantile hemangioma
2013-005199-17Phase 3Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of timolol in Capillary Haemangioma and hemangioma (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Complete or almost complete resolution of target hemangioma at week 24. Started Apr 2014; status: completed.
02
Drugs
timolol
03
Conditions
Capillary Haemangiomahemangioma
Beyond the preview
Go deeper on 2013-005199-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005199-17.